Not Rated
|
Fund Size
(0.09% of Investment in Category)
|
Expense Ratio
(2.12% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 31-Oct-25 | 9968.40 | -0.32% | - | -0.83% | 58/240 |
| 1 Month | 07-Oct-25 | 10135.80 | 1.36% | - | 0.83% | 82/246 |
| 3 Month | 07-Aug-25 | 10081.70 | 0.82% | - | 3.74% | 227/243 |
| 6 Month | 07-May-25 | 10534.40 | 5.34% | - | 8.55% | 181/232 |
| YTD | 01-Jan-25 | 9456.90 | -5.43% | - | 3.55% | 193/219 |
| 1 Year | 07-Nov-24 | 9861.30 | -1.39% | -1.39% | 2.25% | 146/206 |
| Since Inception | 12-Dec-23 | 13582.00 | 35.82% | 17.42% | 12.22% | 60/218 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 07-Nov-24 | 12000 | 12267.41 | 2.23 % | 4.14 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 605.8 | 13.05% | 0.07% | 17.91% (Mar 2025) | 12.98% (Aug 2025) | 3.80 L | 0.00 |
| Max Healthcare Institute Ltd. | Hospital | 340 | 7.33% | -0.21% | 8.58% (Jun 2025) | 3.91% (Nov 2024) | 3.05 L | 0.00 |
| J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 275.3 | 5.93% | -0.02% | 5.95% (Aug 2025) | 3.34% (Oct 2024) | 1.61 L | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 255.6 | 5.51% | -0.28% | 7.08% (Oct 2024) | 4.81% (Jul 2025) | 1.70 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 227.6 | 4.90% | -0.35% | 6.09% (May 2025) | 4.83% (Jan 2025) | 40.00 k | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 196.3 | 4.23% | -0.09% | 4.32% (Aug 2025) | 3.17% (May 2025) | 26.50 k | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 194 | 4.18% | 0.28% | 4.18% (Sep 2025) | 1.85% (Jan 2025) | 2.00 L | 0.00 |
| Lupin Ltd. | Pharmaceuticals | 181.6 | 3.91% | 0.05% | 3.91% (Sep 2025) | 2.86% (Jul 2025) | 95.00 k | 0.00 |
| Jubilant Life Sciences Ltd. | Pharmaceuticals | 151.1 | 3.26% | 0.19% | 4.18% (Oct 2024) | 3.04% (Apr 2025) | 1.40 L | 0.00 |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 140 | 3.02% | 0.69% | 3.02% (Sep 2025) | 2.01% (Oct 2024) | 2.00 L | 50.00 k |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 2.56% |
| Net Receivables | Net Receivables | -0.24% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 406.67 | 1.45 | 18.38 | 60.19 | 40.18 | 39.33 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 266.19 | -1.76 | 3.69 | 18.39 | 25.72 | 17.19 |
| Franklin Asian Equity Fund - Growth | NA | 279.13 | 1.36 | 10.62 | 23.02 | 19.68 | 15.60 |
| Nippon India Japan Equity Fund - Growth | NA | 289.73 | -0.93 | 5.46 | 14.11 | 19.10 | 18.32 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1651.55 | -0.47 | 10.77 | 24.49 | 18.71 | 0.00 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 655.17 | 4.82 | 7.47 | 21.51 | 18.29 | 0.00 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1419.62 | 3.49 | 7.22 | 9.88 | 16.52 | 0.00 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 311.03 | 4.43 | 7.14 | 8.73 | 15.69 | 13.41 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 8693.07 | 2.81 | 5.84 | 11.12 | 15.33 | 19.07 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2014.27 | 3.56 | 5.37 | 9.44 | 13.33 | 17.15 |
Out of 121 mutual fund schemes offered by this AMC, 7 is/are ranked 4 * , 11 is/are ranked 3 * , 8 is/are ranked 2 * , 4 is/are ranked 1 * , and 91 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Kotak Arbitrage Fund - Growth | 3 | 71517.53 | 0.55 | 1.40 | 2.80 | 6.48 | 7.27 |
| Kotak Midcap Fund - Growth | 4 | 58299.59 | -1.47 | 1.97 | 12.81 | 3.60 | 20.91 |
| Kotak Flexi Cap Fund - Growth | 4 | 54083.13 | 0.47 | 2.67 | 7.16 | 6.37 | 15.71 |
| Kotak Money Market Fund - Growth | 4 | 32820.86 | 0.47 | 1.45 | 3.30 | 7.54 | 7.52 |
| Kotak Liquid Fund - Regular Plan - Growth | 2 | 29473.72 | 0.47 | 1.43 | 2.99 | 6.65 | 6.95 |
| Kotak Large & Midcap Fund - Growth | 3 | 28380.64 | 0.40 | 3.83 | 8.90 | 3.44 | 18.00 |
| Kotak Multicap Fund - Regular Plan - Growth | 4 | 20284.98 | 0.78 | 7.05 | 12.90 | 4.30 | 22.22 |
| Kotak Bond Short Term Plan - Growth | 3 | 18155.54 | 0.46 | 1.28 | 2.85 | 7.70 | 7.35 |
| Kotak Corporate Bond Fund - Growth | 3 | 17545.56 | 0.51 | 1.47 | 3.18 | 8.31 | 7.82 |
| Kotak Small Cap Fund - Growth | 2 | 17480.17 | -0.50 | 0.66 | 8.26 | -8.36 | 15.67 |